Vaccination remains the strongest defense against COVID-19. For more information about where you can schedule a vaccine, be tested for COVID-19 or learn more about the virus, visit

COVID-19 Information

Give Now

Gratitude inspires
stories of hope

David Holtzman, MD, and Jeffrey Milbrandt, MD

Curative Treatments for Neurological Disease

One of the things about these disorders is that while they may seem quite different when you see a person who has these problems, there’s a lot in common between them. And one of the ways that we’ve tried to attack that at Washington University and Barnes-Jewish Hospital is through collaboration.

David Holtzman, MD

A New Dawn in Medicine for Neurological Diseases

Advances in research offer new hope for effective therapies for many neurodegenerative diseases. 

Advances in neuroscience offer new hope for discovery of effective therapies for many neurodegenerative diseases such as ALS, Alzheimer’s, Parkinson’s and Huntington’s.

Because the scientific principles of nervous system degeneration and repair are shared by many different neurological diseases, interdisciplinary collaboration is key to developing groundbreaking treatments, say physician scientists David Holtzman, MD, and Jeffrey Milbrandt, MD.

Dr. Holtzman is the Andrew B. and Gretchen P. Jones Professor and Chair of the Department of Neurology, scientific director of the Hope Center for Neurological Disorders, and associate director of the Knight Alzheimer’s Disease Research Center at the Washington University School of Medicine. Dr. Milbrandt, is the James S. McDonnell and head of the Department of Genetics, Executive Director of the McDonnell Genome Institute, and Co-Director of the Needleman Center for Neurometabolism and Axonal Therapeutics, as well as the professor of pathology.